Literature DB >> 39554

Purification and properties of N-acetylgalactosamine 6-sulphate sulphatase from human placenta.

J Glössl, W Truppe, H Kresse.   

Abstract

1. N-Acetylgalactosamine 6-sulphate sulphatase was purified about 20000-fold from the soluble extract of human placenta with N-acetylgalactosamine 6-sulphate-glucuronic acid-N-acetyl[1-(3)H]galactosaminitol 6-sulphate as substrate in the activity assay. The enzyme appears to be a glycoprotein with a mol.wt. of about 100000 as determined by gel filtration. On gel electrophoresis in the presence of sodium dodecyl sulphate the major protein band had a mol.wt. of 78000. Variable charge heterogeneity was observed in several enzyme preparations. 2. The purified enzyme released up to one sulphate molecule from the disulphated trisaccharide. It was active towards N-acetylgalactosamine 6-sulphate and exhibited no measurable N-acetylglucosamine 6-sulphate sulphatase or any other known lysosomal sulphatase activity. Hydrolysis of [1-(3)H]galactitol 6-sulphate was achieved by incubation neither with a crude nor with a purified enzyme preparation. Chondroitin 6-sulphate and keratan sulphate, as well as heparin and heparan sulphate, served as competitive inhibitors of the enzyme. 3. Purified N-acetylgalactosamine 6-sulphate sulphatase activity was optimal at pH4.9 and 4.4 when assayed in 0.02m-sodium acetate buffer and at pH4.2 and 5.2 in 0.1m-sodium acetate buffer. A single pH-optimum at pH4.8 was observed for the crude enzyme and for the purified enzyme after mild periodate treatment. The sulphatase activity was inhibited by a variety of anions and cations and activated by thiol-specific and thiol reagents.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 39554      PMCID: PMC1161122          DOI: 10.1042/bj1810037

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  A modified uronic acid carbazole reaction.

Authors:  T BITTER; H M MUIR
Journal:  Anal Biochem       Date:  1962-10       Impact factor: 3.365

2.  The assay of arylsulphatases A and B in human urine.

Authors:  H BAUM; K S DODGSON; B SPENCER
Journal:  Clin Chim Acta       Date:  1959-05       Impact factor: 3.786

3.  Studies on sulphatases. 21. The anomalous kinetics of arylsulphatase A of human tissues: the anomalies.

Authors:  H BAUM; K S DODGSON; B SPENCER
Journal:  Biochem J       Date:  1958-08       Impact factor: 3.857

4.  The degradation of cartilage chondroitin sulphate by the chondroitinase of Proteus vulgaris.

Authors:  K S DODGSON; A G LLOYD
Journal:  Biochem J       Date:  1958-01       Impact factor: 3.857

5.  Studies on sulphatases. VII. A preliminary account of the glycosulphatase of Littorina littorea.

Authors:  K S DODGSON; B SPENCER
Journal:  Biochem J       Date:  1954-06       Impact factor: 3.857

6.  Fractionation of the products of the direct sulphation of monosaccharides on anion-exchange resin.

Authors:  A G LLOYD
Journal:  Biochem J       Date:  1962-06       Impact factor: 3.857

7.  Isolation and identification of keratosulphate in urine of patients affected by Morquio-Ullrich disease.

Authors:  V PEDRINI; L LENNZI; V ZAMBOTTI
Journal:  Proc Soc Exp Biol Med       Date:  1962 Aug-Sep

8.  A sulphated mucopolysaccharide in human dentine.

Authors:  P PINCUS
Journal:  Nature       Date:  1950-07-29       Impact factor: 49.962

9.  Purification and properties of arylsulphatase A from rabbit testis.

Authors:  C H Yang; P N Srivastava
Journal:  Biochem J       Date:  1976-10-01       Impact factor: 3.857

10.  Deficiencies of glucosamine-6-sulfate or galactosamine-6-sulfate sulfatases are responsible for different mucopolysaccharidoses.

Authors:  N Di Ferrante; L C Ginsberg; P V Donnelly; D T Di Ferrante; C T Caskey
Journal:  Science       Date:  1978-01-06       Impact factor: 47.728

View more
  8 in total

Review 1.  Chondroitin sulfate/dermatan sulfate sulfatases from mammals and bacteria.

Authors:  Shumin Wang; Kazuyuki Sugahara; Fuchuan Li
Journal:  Glycoconj J       Date:  2016-08-15       Impact factor: 2.916

2.  Human liver N-acetylgalactosamine 6-sulphatase. Purification and characterization.

Authors:  J Bielicki; J J Hopwood
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

3.  Morquio's disease type A: absence of material cross reacting with antibodies against N-acetylgalactosamine-6-sulfate sulfatase.

Authors:  J Glössl; K Lembeck; G Gamse; H Kresse
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

4.  The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A.

Authors:  Yadilette Rivera-Colón; Emily K Schutsky; Adriana Z Kita; Scott C Garman
Journal:  J Mol Biol       Date:  2012-08-29       Impact factor: 5.469

5.  Impaired degradation of keratan sulphate by Morquio A fibroblasts.

Authors:  J Glössl; H Kresse
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

6.  Multiple forms of 2-deoxy-D-glucoside-2-sulphamate sulphohydrolase from human placenta.

Authors:  E Paschke; H Kresse
Journal:  Biochem J       Date:  1979-09-01       Impact factor: 3.857

7.  Degradation of keratan sulphate by beta-N-acetylhexosaminidases A and B.

Authors:  T Ludolph; E Paschke; J Glössl; H Kresse
Journal:  Biochem J       Date:  1981-03-01       Impact factor: 3.857

8.  Recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in the methylotrophic yeast Pichia pastoris.

Authors:  Alexander Rodríguez-López; Carlos J Alméciga-Díaz; Jhonnathan Sánchez; Jefferson Moreno; Laura Beltran; Dennis Díaz; Andrea Pardo; Aura María Ramírez; Angela J Espejo-Mojica; Luisa Pimentel; Luis A Barrera
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.